Adamas Pharmaceuticals, Inc.: capex
| Value | {"amount": 194000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2014-01-01 – 2014-06-30 |
| Status | current |
| Entity | Adamas Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:42:17.795211+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4e3ec696-36d3-464b-9901-e5c4523309cb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-14-058311 · Open the official SEC filing →Retrieved: 2026-08-19T12:42:17.795211+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001328143/capex/2014-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4e3ec696-36d3-464b-9901-e5c4523309cb
History
- no predecessors — first report